182 related articles for article (PubMed ID: 32702607)
1. No promising antidote 25 years after the Tokyo subway sarin attack: A review.
Sakurada K; Ohta H
Leg Med (Tokyo); 2020 Nov; 47():101761. PubMed ID: 32702607
[TBL] [Abstract][Full Text] [Related]
2. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack.
Tokuda Y; Kikuchi M; Takahashi O; Stein GH
Resuscitation; 2006 Feb; 68(2):193-202. PubMed ID: 16325985
[TBL] [Abstract][Full Text] [Related]
3. Support for relationship between serum cholinesterase and post-traumatic stress disorder; 5-year follow-ups of victims of the Tokyo subway sarin poisoning.
Tochigi M; Otani T; Yamasue H; Kasai K; Kato T; Iwanami A; Kato N; Sasaki T
Neurosci Res; 2005 Jun; 52(2):129-31. PubMed ID: 15876465
[No Abstract] [Full Text] [Related]
4. The Tokyo subway sarin attack--lessons learned.
Okumura T; Hisaoka T; Yamada A; Naito T; Isonuma H; Okumura S; Miura K; Sakurada M; Maekawa H; Ishimatsu S; Takasu N; Suzuki K
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):471-6. PubMed ID: 15979676
[TBL] [Abstract][Full Text] [Related]
5. The Tokyo subway sarin attack has long-term effects on survivors: A 10-year study started 5 years after the terrorist incident.
Sugiyama A; Matsuoka T; Sakamune K; Akita T; Makita R; Kimura S; Kuroiwa Y; Nagao M; Tanaka J
PLoS One; 2020; 15(6):e0234967. PubMed ID: 32574198
[TBL] [Abstract][Full Text] [Related]
6. Report on 640 victims of the Tokyo subway sarin attack.
Okumura T; Takasu N; Ishimatsu S; Miyanoki S; Mitsuhashi A; Kumada K; Tanaka K; Hinohara S
Ann Emerg Med; 1996 Aug; 28(2):129-35. PubMed ID: 8759575
[No Abstract] [Full Text] [Related]
7. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.
Koplovitz I; Stewart JR
Toxicol Lett; 1994 Feb; 70(3):269-79. PubMed ID: 8284794
[TBL] [Abstract][Full Text] [Related]
8. What lessons can we learn from the Japanese sarin attacks?
Vale A
Przegl Lek; 2005; 62(6):528-32. PubMed ID: 16225116
[TBL] [Abstract][Full Text] [Related]
9. Serum cholesterol, uric acid and cholinesterase in victims of the Tokyo subway sarin poisoning: a relation with post-traumatic stress disorder.
Tochigi M; Umekage T; Otani T; Kato T; Iwanami A; Asukai N; Sasaki T; Kato N
Neurosci Res; 2002 Nov; 44(3):267-72. PubMed ID: 12413655
[TBL] [Abstract][Full Text] [Related]
10. Expression of paraoxonase isoform did not confer protection from acute sarin poisoning in the Tokyo subway terrorist attack.
Yamada Y; Takatori T; Nagao M; Iwase H; Kuroda N; Yanagida J; Shinozuka T
Int J Legal Med; 2001 Oct; 115(2):82-4. PubMed ID: 11724436
[TBL] [Abstract][Full Text] [Related]
11. Development of forensic diagnosis of acute sarin poisoning.
Nagao M; Takatori T; Maeno Y; Isobe I; Koyama H; Tsuchimochi T
Leg Med (Tokyo); 2003 Mar; 5 Suppl 1():S34-40. PubMed ID: 12935549
[TBL] [Abstract][Full Text] [Related]
12. Translational toxicology from basic sciences to clinical toxicology Sequelae of victims in Tokyo subway sarin attack.
Ishimatsu S
Chudoku Kenkyu; 2016 Sep; 29(3):264-267. PubMed ID: 30549946
[No Abstract] [Full Text] [Related]
13. Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack.
Miyaki K; Nishiwaki Y; Maekawa K; Ogawa Y; Asukai N; Yoshimura K; Etoh N; Matsumoto Y; Kikuchi Y; Kumagai N; Omae K
J Occup Health; 2005 Jul; 47(4):299-304. PubMed ID: 16096354
[TBL] [Abstract][Full Text] [Related]
14. Treatment of sarin exposure.
Schier JG; Hoffman RS
JAMA; 2004 Jan; 291(2):182; author reply 182-3. PubMed ID: 14722139
[No Abstract] [Full Text] [Related]
15. Limitations and challenges in treatment of acute chemical warfare agent poisoning.
Thiermann H; Worek F; Kehe K
Chem Biol Interact; 2013 Dec; 206(3):435-43. PubMed ID: 24091052
[TBL] [Abstract][Full Text] [Related]
16. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning.
Yokoyama K; Araki S; Murata K; Nishikitani M; Okumura T; Ishimatsu S; Takasu N
J Physiol Paris; 1998; 92(3-4):317-23. PubMed ID: 9789830
[TBL] [Abstract][Full Text] [Related]
17. Nerve agents: implications for anesthesia providers.
Hrobak PK
AANA J; 2008 Apr; 76(2):95-7. PubMed ID: 18478812
[TBL] [Abstract][Full Text] [Related]
18. Sarin experiences in Japan: acute toxicity and long-term effects.
Yanagisawa N; Morita H; Nakajima T
J Neurol Sci; 2006 Nov; 249(1):76-85. PubMed ID: 16962140
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
20. New safe method for preparation of sarin-exposed human erythrocytes acetylcholinesterase using non-toxic and stable sarin analogue isopropyl p-nitrophenyl methylphosphonate and its application to evaluation of nerve agent antidotes.
Ohta H; Ohmori T; Suzuki S; Ikegaya H; Sakurada K; Takatori T
Pharm Res; 2006 Dec; 23(12):2827-33. PubMed ID: 17096183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
